Head-to-head · Cost-Efficiency Index
Hello Alpha vs DrMedHealth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Hello Alpha
Cost-first shoppers who want existing or prospective Hello Alpha women's-health patients who want branded (not compounded) GLP-1 prescribing folded into the same platform.
Visit Hello AlphaDrMedHealth
Shoppers who want a simple flat rate that doesn't increase as their dose titrates up.
Visit DrMedHealthThe verdict
Hello Alpha takes it, leading the Cost-Efficiency Index 67 to 66. Hello Alpha is a well-established women's telehealth brand that also genuinely prescribes FDA-approved branded GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound, and orforglipron/Foundayo) rather than compounded versions. DrMedHealth still earns a C — Shoppers who want a simple flat rate that doesn't increase as their dose titrates up.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Hello Alpha.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Hello Alpha | DrMedHealth |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 66/100 |
| Semaglutide / mo | $79/mo (brand Wegovy, plus a separate fee) | $199/mo (all doses, compounded oral) |
| Tirzepatide / mo | $79/mo (brand Mounjaro, plus a separate fee) | $299/mo (all doses, compounded oral) |
| Semaglutide / yr (modeled) | $948 | $2,388 |
| Tirzepatide / yr (modeled) | $948 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #138 | #145 |
Hello Alpha
67/100Where the value is
- Only prescribes FDA-approved branded GLP-1s (no compounding risk/variability)
- Established, well-known women's telehealth brand with a named Chief Medical Officer (Dr. Loni Belyea)
- Broad medication menu includes newer options like oral orforglipron (Foundayo)
The tradeoffs
- The $79/mo headline figure is a membership fee, NOT the drug price
- Site explicitly states a prescription is not guaranteed by membership
DrMedHealth
66/100Where the value is
- Flat pricing regardless of dose -- no hidden dose-escalation cost
- Both injectable and oral forms offered for each drug
- LegitScript certified with nationwide (50 states + DC) coverage
The tradeoffs
- No single named medical director, just a list of prescribing providers
- Site is a JS-heavy SPA that renders nothing to basic fetchers, complicating independent verification
Regulatory note: the FDA issued a warning letter to Public Health Solution LLC dba DrMedHealth in June 2026. We still list and link to DrMedHealth; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.